The total return over the past 12 months is -49.83% vs. +16.94% for the S&P 500. So far it's up -32.25% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (49.83%) | (15.65%) | (40.75%) | (32.84%) | (36.25%) | (37.29%) |
| Total Return CAGR | (49.83%) | (15.64%) | (40.75%) | (32.84%) | (36.25%) | (37.29%) |
| Revenue CAGR | (90.65%) | N/A | N/A | (43.33%) | (35.55%) | +6.61% |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Lisata Therapeutics, Inc. (LSTA)
| Year | Start price | End price | LSTA Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.86 | $1.26 | (32.25%) | +14.51% | (46.76%) |
| 2025 | $2.98 | $1.86 | (37.58%) | +17.72% | (55.30%) |
| 2024 | $2.73 | $2.98 | +9.14% | +24.89% | (15.75%) |
| 2023 | $2.53 | $2.73 | +7.95% | +26.19% | (18.24%) |
| 2022 | $12.60 | $2.53 | (79.93%) | (18.17%) | (61.76%) |
| 2021 | $21.45 | $12.60 | (41.26%) | +28.74% | (70.00%) |
| 2020 | $37.65 | $21.45 | (43.03%) | +18.37% | (61.40%) |
| 2019 | $53.40 | $37.65 | (29.49%) | +31.22% | (60.71%) |
| 2018 | $52.65 | $53.40 | +1.43% | (4.56%) | +5.99% |
| 2017 | $42.45 | $52.65 | +24.03% | +21.70% | +2.33% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
